Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Diabetes mellitus type 1 Stories

2014-01-02 08:23:12

JERUSALEM, January 2, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. [http://www.oramed.com ] (NASDAQCM: ORMP) ( http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has received Notices of Allowance from the Israel and Australian Patent Office [http://www.ilpatsearch.justice.gov.il/UI/RequestDetails.aspx?ReqId=208165 ]s. The patent entitled, "Methods and Compositions for Oral Administrations of Proteins" covers a core concept...

2013-12-28 23:02:58

Reverse Your Diabetes Today is a new and safe diabetes cure that is created by Matt Traverso that claims to help people cure their diabetes quickly. A full Reverse Your Diabetes Today review on the site hynguyenblog.com shows whether this method is reliable to use. (PRWEB) December 28, 2013 Reverse Your Diabetes Today is a newly updated diabetes cure developed by Matt Traverso that claims to help patients banish their diabetes forever. This natural home remedy promises to heal this...

2013-12-24 20:20:28

JERUSALEM, Dec. 24, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, today announced that it has entered into definitive agreements with investors to purchase an aggregate of 1,580,000 shares of common stock at a price of $10.00 per share in a registered direct offering. The offering is expected to close on or about December 31, 2013, subject to the satisfaction of customary closing conditions. Oramed intends to use the...

2013-12-20 20:21:14

SAN DIEGO, Dec. 20, 2013 /PRNewswire/ -- Tandem Diabetes Care(®), Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim(®) Insulin Pump, today announced that the company was added to the Russell 2000® and Russell 3000® Indexes following reconstitution of Russell Investment Group's family of US indexes after market close on December 20, 2013. (Logo: http://photos.prnewswire.com/prnh/20131220/LA37333LOGO) "Being added to the Russell 2000 and Russell 3000...

2013-12-20 12:24:35

DUBLIN, Dec. 20,2013. /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/zrrwvb/research_report) has announced the addition of the "Research Report on China's Diabetes Drug Market, 2013-2017" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Diabetes refers to a series of metabolic disorder syndrome such as sugars, proteins, fat, water and electrolyte that are triggered by islet dysfunction and insulin resistance, and...

2013-12-20 08:25:31

Company Additionally Anticipates Results from Phase 2a FDA Study for Type 2 Diabetes in January JERUSALEM, Dec. 20, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today successful results in a clinical trial testing the pharmacokinetic dose response of its oral insulin capsule (ORMD-0801) in type 1 diabetes patients. Patients were...

2013-12-19 12:25:52

New resources housed on T1EverydayMagic.com combine the expertise of Lilly Diabetes with the magic of Disney INDIANAPOLIS, Dec. 19, 2013 /PRNewswire/ -- Lilly Diabetes and Disney today announced that their custom books for children and families with type 1 diabetes are now available online. The digital books explore real-life challenges and stories of children with type 1 diabetes participating in sporting activities, birthday parties and other social events. These digital books can be...

2013-12-19 08:28:04

SAN DIEGO, Dec. 19, 2013 /PRNewswire/ -- ViaCyte, Inc., a leading regenerative medicine company developing a transformative cell therapy for treatment of diabetes, announced today that Mark G. Foletta has been appointed to its Board of Directors. (Logo: http://photos.prnewswire.com/prnh/20121026/LA00871LOGO-a) Mr. Foletta is a seasoned financial executive with over 30 years of corporate experience. He was most recently senior vice president and Chief Financial Officer at Amylin...

2013-12-17 12:26:10

--JDRF announces Road ID as a new partner in the JDRF Bag of Hope. The medical identification company is providing each JDRF Bag of Hope with a coupon for a personalized Road ID bracelet.-- NEW YORK, Dec. 17, 2013 /PRNewswire-USNewswire/ -- JDRF is excited to announce Road ID as a new partner in the JDRF Bag of Hope, a free resource for children newly diagnosed with type 1 diabetes (T1D) and their caregivers. The JDRF Bag of Hope is a backpack filled with useful and educational...

2013-12-17 08:30:16

OAKLAND, Calif., Dec. 17, 2013 /PRNewswire/ -- The duration of diabetes, as well as advancing age, independently predict diabetes severity and risk of death for older adults with type 2 diabetes, according to a study published online in JAMA Internal Medicine. (Logo: http://photos.prnewswire.com/prnh/20130718/SF49717LOGO) In this study led by Kaiser Permanente and the University of Chicago, researchers investigated contemporary rates of diabetes complications and risk of death,...


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »